Pieris Pharmaceuticals
1 follower
‌
Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way.
Industries
Headquarters
Employees
Links
Org chart
Stephen S. Yoder
President & CEO
Stephen S. Yoder
Collapse
Tom Bures
SVP & CFO
Shane Olwill
SVP & Chief Development Officer
Mary Fitzgerald
VP, Project Leader PRS-060/AZD1402
Frank Vollmering
VP, Human Resources
Florian Witte
VP & Head of Alliance Management and Early-Stage Project Leadership
